CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
ubiquinol (reduced coenzyme Q10) +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05178225
NCT05178225N/ACompleted
CompareCT.gov

Spa Rehabilitation, Antioxidant and Bioenergetic Supportive Treatment of Patients With Post-Covid-19 Syndrome

Comenius University·interventional·Posted Jan 5, 2022·Updated Jan 20, 2022

In Brief

A clinical study evaluating ubiquinol (reduced coenzyme Q10), mountain spa rehabilitation, and 1 other intervention for COVID-19 Respiratory Infection. Completed, enrolled 51 participants across 1 site.

Detailed Summary

Our hypothesis - that 21 days of mountain spa rehabilitation with ubiquinol supplementation could to accelerate regeneration of patients with post-COVID-19 syndrome, based on the improving platelet mitochondrial bioenergetic, decreasing of oxidative stress and improving of antioxidants protections of patients with post-COVID-19 syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19 Respiratory Infection
CountriesSlovakia
CollaboratorsSanatórium of Dr. Guhr, n.o., Kaneka Pharma Europe N.V.

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 5, 2022
Enrollment StartMay 1, 2021
Primary CompletionJun 30, 2021
Study CompletionJan 1, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.5 years ago

Interventions

ubiquinol (reduced coenzyme Q10)dietary

supplementation with ubiquinol (reduced coenzyme Q10), in a daily dose of 2x100 mg. one morning after breakfast, and second dose after dinner.

mountain spa rehabilitationother

special spa rehabilitation in the mountain High Tatras; Functional capacity of the lungs (6MWT) at before and after 16-18 days of rehabilitation, Borg scale for dyspnea and oxygen saturation SpO2 (%) were monitored.

2x14 ml of peripheral blood collected in a tube with anticoagulantother

2x14 ml of peripheral blood collected in a tube with anticoagulant